Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Inhalable polymer nanoparticles for versatile mRNA delivery and mucosal vaccination

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.03.22.485401Source: DataRank Database

Inhalable polymer nanoparticles for versatile mRNA delivery and mucosal vaccination is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2022). On theSindex it has a DataRank of 0. It has been cited 18 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access18 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)OA: greenTopics (18)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Molly K. Grun ORCID,Tianyang Mao ORCID,Benjamin Israelow ORCID,Melanie Reschke ORCID,Julian Grundler ORCID

Live enrichment

PubMed:35350207 OpenAlex:https://openalex.org/W4220744544

National Institutes of Health

Grant: 5T32AI007019-16

INTERDISCIPLINARY IMMUNOLOGY

National Institutes of Health

Grant: 3R01AI157488-02S1

Viral and immune-mediated CNS pathology during SARS-CoV-2 infection

National Institutes of Health

Grant: 1K99HL151806-01A1

Developing Gene Editing Therapeutics, Biodegradable Polymeric Delivery Vehicles, and High-throughput Platforms for the Treatment of Cystic Fibrosis

National Institutes of Health

Grant: 1K08AI163493-01

Innate Control of Adaptive Immunity to SARS-CoV-2

National Institutes of Health

Grant: 1UG3HL147352-01

Poly(amine-co-ester)s for Targeted Delivery In Vivo of Gene Editing Agents to Bone Marrow and Lung

National Institutes of Health

Grant: 2T32AI007517-16

Training in Investigative Infectious Diseases

National Institutes of Health

Grant: 3T32GM136651-02S2

Medical Scientist Training Program

NHLBI NIH HHS

Grant: K99 HL151806

NHLBI NIH HHS

Grant: R00 HL151806

green

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2022/03/23/2022.03.22.485401.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2022.03.22.485401

repositoryhttps://doi.org/10.1101/2022.03.22.485401

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35350207

Fields of Study

RNA Interference and Gene DeliveryInhalation and Respiratory Drug DeliveryNanoparticle-Based Drug Delivery0301 basic medicine03 medical and health sciences

Keywords

Messenger RNATransfectionImmunityLungPolyethylene glycolVaccinationGene deliveryImmune systemChemistryImmunologyMedicineBiochemistryGene

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being